Enzymatic Methylation of Arsenic Compounds
- PMID: 8813004
Enzymatic Methylation of Arsenic Compounds
Abstract
The methylation of inorganic arsenic to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) have been generally considered to be the major pathway for inorganic arsenic biotransformation and detoxification. Yet, when arsenate/arsenite is injected into the Callithrix jacchus (marmoset) monkey or chimpanzee, monomethylarsonic acid and dimethylarsinic acid are not found in the urine. With the development of a rapid assay for the methyltransferases of arsenic metabolism, we have investigated the methyltransferases of the marmoset monkey liver. We have found that the marmoset, a New World animal, is deficient in liver arsenite and monomethylarsonic acid methyltransferase activities. However, the rhesus monkey, an Old World animal, has ample amounts of such methyltransferase activities. The tamarin, another New World species, is also deficient in these methyltransferases. Polymorphism and deficiency of these methyltransferases may have allowed high levels of arsenite to be maintained in the blood and liver of the marmoset and tamarin. Such high levels of arsenite may have been selective for survival of the species. The rhesus liver methyltransferases for arsenite and MMA have been purified and found to have some properties different from those of the previously reported purified rabbit liver activities. The rhesus and rabbit liver arsenite and MMA methyltransferases are devoid of catechol O-methyltransferase activity.
Similar articles
-
Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic.Toxicol Appl Pharmacol. 1996 Sep;140(1):77-84. doi: 10.1006/taap.1996.0199. Toxicol Appl Pharmacol. 1996. PMID: 8806872
-
Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro.Toxicol Appl Pharmacol. 1998 Oct;152(2):366-75. doi: 10.1006/taap.1998.8409. Toxicol Appl Pharmacol. 1998. PMID: 9853005
-
A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.Arch Toxicol. 2005 Apr;79(4):183-91. doi: 10.1007/s00204-004-0620-x. Epub 2004 Nov 4. Arch Toxicol. 2005. PMID: 15526190
-
Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.Annu Rev Pharmacol Toxicol. 1997;37:397-419. doi: 10.1146/annurev.pharmtox.37.1.397. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131259 Review.
-
A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.Toxicol Appl Pharmacol. 2004 Aug 1;198(3):327-35. doi: 10.1016/j.taap.2003.10.027. Toxicol Appl Pharmacol. 2004. PMID: 15276412 Review.
Cited by
-
The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.Epidemiology. 2015 Jul;26(4):601-12. doi: 10.1097/EDE.0000000000000313. Epidemiology. 2015. PMID: 25929811 Free PMC article.
-
Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression.Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10907-12. doi: 10.1073/pnas.94.20.10907. Proc Natl Acad Sci U S A. 1997. PMID: 9380733 Free PMC article.